Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00248573 · ClinicalTrials.gov registry record
Mechanisms of Adaptation in Human Short Bowel Syndrome
A clinical trial, sponsored by Emory University.
- Completed
- Registry status
- 32
- Enrollment target
NCT00248573 is a clinical trial that has completed, run by Emory University. The registered enrollment target is 32 participants.
The verdict
NCT00248573 has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- 32 participants
- Enrollment target
Study Summary
This is an observational, natural history trial of mechanisms of gut adaptation in adult short bowel syndrome (SBS). Patients with SBS (\< 200 cm small bowel ± colon) will be studied initially 2-9 months after the last small bowel resection and again exactly 6 months after the initial study. GCRC-studies will examine intestinal nutrient absorption, gut barrier functions and gut mucosal biopsy specimens for markers of nutrient transport and cell proliferation and apoptosis.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2004-10 |
| Est. Completion | 2013-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00248573
The ClinicalTrials.gov registry entry for NCT00248573 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00248573 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00248573 about?
NCT00248573 is a clinical study titled "Mechanisms of Adaptation in Human Short Bowel Syndrome". This is an observational, natural history trial of mechanisms of gut adaptation in adult short bowel syndrome (SBS). Patients with SBS (\< 200 cm small bowel ± colon) will be studied initially 2-9 months after the last small bowel resection and again exactly 6 months after the initial study. GCRC-st...
What is the current status of trial NCT00248573?
This trial is currently completed. The enrollment target is 32 participants. The study started on 2004-10. Estimated completion is 2013-07.
Who is sponsoring clinical trial NCT00248573?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.